A new study led by Monash University and Alfred Health found a 70% reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of an HPV vaccination program in 2013.
Published in Lancet Infectious Diseases on May 24, 2021, the HYPER2 study found a significant reduction in vaccine-preventable HPV genotypes in men who have sex with men (MSM) aged 16-20 years following the introduction of the vaccine.
And the decrease in anal HPV 16 and 18 may lead to a reduction in the incidence of anal cancer.
Bisexual and Gay Men Benefit from HPV Vaccination
Moderna COVID-19 Vaccine Highly Effective in Children 12 and Older
Side effects among adolescents who received the Moderna vaccine were similar to those reported in adults
U.S. Issues Tough Travel Warnings for Japan Ahead of Olympics
Travel advisories issued by both the U.S. Centers for Disease Control and Prevention and the U.S. State Department